Eton Pharmaceuticals, Inc. · NASDAQ:ETON

Krempa David sold 100,000 Eton Pharmaceuticals, Inc. shares (Form 4)

Traded May 22 to May 27, 2026 · Filed May 27, 2026

From May 22 to May 27, 2026, Krempa David (Chief Business Officer) sold 100,000 Eton Pharmaceuticals, Inc. shares at an average US$32.30 for US$3.23M, leaving 25,249 shares. Filed May 27, 2026 (Form 4).

Sold
100,000 shares
Price
US$32.30 average (US$31.47 to US$35.00)
Value
US$3.23M
Holding after
25,249 shares
Trading plan
No
Role
Chief Business Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 22, 2026Common StockOption exercise30,591US$3.5868,046Direct
May 22, 2026Common StockSale32,963US$33.2235,083Direct
May 22, 2026Common StockSale9,315US$33.8825,768Direct
May 22, 2026Common StockSale519US$35.0025,249Direct
May 26, 2026Common StockOption exercise25,000US$1.3850,249Direct
May 26, 2026Common StockOption exercise12,524US$1.3762,773Direct
May 26, 2026Common StockSale37,524US$31.4925,249Direct
May 27, 2026Common StockOption exercise12,476US$1.3737,725Direct
May 27, 2026Common StockOption exercise7,203US$3.5844,928Direct
May 27, 2026Common StockSale19,679US$31.4725,249Direct

Source

View original at SEC

Related